Two Sigma Investments
GMDA

Two Sigma Investments’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Two Sigma Investments’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-106,081
Closed -$3.83K – 3460
2024
Q1 		$3.83K Sell
106,081
-18,145
-15% -$6.2K ﹤0.01% 2976
2023
Q4 		$51.3K Buy
124,226
+111,126
+848% +$62.7K ﹤0.01% 2992
2023
Q3 		$13.5K Sell
13,100
-16,533
-56% -$21.1K ﹤0.01% 2888
2023
Q2 		$57.2K Buy
29,633
+9,033
+44% +$15.5K ﹤0.01% 2812
2023
Q1 		$16.7K Buy
+20,600
New +$30.1K ﹤0.01% 2862
2022
Q1 		– Sell
-16,394
Closed -$42K – 4638
2021
Q4 		$42K Sell
16,394
-137,279
-89% -$452K ﹤0.01% 4150
2021
Q3 		$602K Buy
153,673
+91,086
+146% +$455K ﹤0.01% 3076
2021
Q2 		$401K Buy
+62,587
New +$431K ﹤0.01% 3283
2021
Q1 		– Sell
-24,604
Closed -$206K – 4346
2020
Q4 		$206K Sell
24,604
-29,691
-55% -$201K ﹤0.01% 3105
2020
Q3 		$225K Buy
+54,295
New +$231K ﹤0.01% 2754

Other funds holding GMDA

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Investments's GMDA Position: Q2 2024 in Review

Two Sigma Investments sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 106,081 shares — an estimated $3.83K sold.

Two Sigma Investments first reported a position in GMDA in Q3 2020 and held it in 10 quarters. The position peaked at $602K in Q3 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

  • Two Sigma Investments reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 106,081 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $3.83K.
  • Two Sigma Investments first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 10 quarters.
  • Two Sigma Investments's Gamida Cell Ltd. Ordinary Shares position peaked at $602K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.